Talking the same language
Download full article
September 2009
Eric Van Cutsem: closing in on GI tumours
Eric Van Cutsem has been at the forefront of developing new molecular therapies for gastrointestinal cancers, but he’s not relying on finding that magic bullet. He advocates a many-fronted attack, combining genetic counselling with screening [more]
State-of-the-art and controversies in germ-cell cancer
Many different, intersecting strategies are available for managing germ-cell cancers, particularly in early-stage disease. Which is right’ remains a matter of debate, and requires balancing efficacy against late effects, bearing in mind the complexity of [more]
Gotta get that rhythm – Circadian timing systems and cancer
The role of circadian rhythms in cancer hit the headlines this year because of growing evidence that night shift work may increase the risk of breast cancer. But could a better understanding of the role [more]
Are we educating women to be afraid? UK health reporter questions the value of simplistic screening messages
Breast screening programmes won’t work if women don’t attend. But can this justify campaigns that exaggerate both the risk of getting breast cancer and the benefits of screening? Margaret McCartney believes not. She won a [more]
Vested interests are undermining our efforts to beat cancer – The worries of a battle-hardened German oncologist
Cancer treatment is at a critical juncture, says Dieter K Hossfeld, veteran campaigner for the recognition of medical oncology in Germany. Future progress, he believes, depends on reasserting the interests of society at large over [more]
Effect of treatment interruptions in prostate cancer
A recent study has shown that treatment interruptions during a fractionated external-beam radiotherapy course for localised prostate cancers may have a negative effect on patient outcome. Limiting or modifying the overall elapsed time between treatments [more]
Endocrine-therapy-related symptoms and breast cancer
The association of a treatment-related adverse effect with treatment success has been reported in various clinical situations. The development of vasomotor or joint symptoms is an indication of therapeutic benefit in women receiving endocrine treatment [more]
Newsround
Selected reports edited by Janet Fricker Download full article
A man with a woman’s cancer How can we do better for male breast cancer patients?
Being diagnosed with a woman’s cancer can pose all sorts of problems for a man. Should breast cancer advocacy groups be more welcoming? Do men need their own groups, or don’t they do that sort [more]